LifeStance Health Group, Inc. (LFST) Operating Margin
- Operating margin · 12 months: Value 4.95%; Formula and calculation Operating income / revenue. Period ending 2026-06-30..
Operating margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Operating margin · 12 months | 4.95% | Operating income / revenue. Period ending 2026-06-30. $78.43M ÷ $1.58B × 100 ≈ 4.95% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating income | 78.43M USD | Operating Income (Loss) |
| Revenue | 1.58B USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | (m) | |
| Research and development | (m) | |
| Selling, general and administration | 398.86M USD | Selling, General and Administrative Expense |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Operating income (USD) | Revenue (USD) | Cost of products and services (USD) | Research and development (USD) | Selling, general and administration (USD) | Operating margin |
|---|---|---|---|---|---|---|
| 2026-06-30 | $78.43M | $1.58B | (m) | (m) | $398.86M | 4.95% |
| 2026-03-31 | $44.83M | $1.49B | (m) | (m) | $388.10M | 3.00% |
| 2025-12-31 | $24.15M | $1.42B | (m) | (m) | $382.20M | 1.70% |
| 2025-09-30 | $7.12M | $1.37B | (m) | (m) | $381.13M | 0.52% |
| 2025-06-30 | $-240.00K | $1.32B | (m) | (m) | $370.78M | -0.02% |
| 2025-03-31 | $-13.24M | $1.28B | (m) | (m) | $368.56M | -1.03% |
| 2024-12-31 | $-31.61M | $1.25B | (m) | (m) | $363.06M | -2.53% |
| 2024-09-30 | $-64.94M | $1.21B | (m) | (m) | $362.72M | -5.38% |
| 2024-06-30 | $-139.35M | $1.16B | (m) | (m) | $408.40M | -12.05% |
| 2024-03-31 | $-171.81M | $1.10B | (m) | (m) | $415.10M | -15.57% |
| 2023-12-31 | $-189.13M | $1.06B | (m) | (m) | $410.79M | -17.92% |
| 2023-09-30 | $-202.88M | $1.00B | (m) | (m) | $407.24M | -20.20% |
| 2023-06-30 | $-167.36M | $959.09M | (m) | (m) | $357.55M | -17.45% |
| 2023-03-31 | $-179.42M | $909.04M | (m) | (m) | $359.25M | -19.74% |
| 2022-12-31 | $-210.17M | $859.54M | (m) | (m) | $377.99M | -24.45% |
| 2022-09-30 | $-277.92M | $630.18M | (m) | (m) | $440.83M | -44.10% |
| 2022-06-30 | $-363.75M | $412.62M | (m) | (m) | $522.52M | -88.16% |
| 2022-03-31 | $-350.32M | $61.41M | (m) | (m) | $504.44M | -570.48% |
| 2021-12-31 | $-286.35M | $1.45M | (m) | (m) | $433.73M | -19816.82% |
| 2021-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-03-31 | $5.86M | $143.27M | (m) | (m) | $84.49M | 4.09% |
| 2020-12-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-05-14 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-12-31 | $15.24M | $212.52M | (m) | (m) | $41.06M | 7.17% |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B |